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rise to serious concerns by feminists internationally. Their questions ranged from asking about health 
risks to ethical and political problems inherent in these technologies. However, over the last 25 years, 
interest in women’s health which used to be central to feminist theory and politics, progressively 
decreased and with it concerns about ART. Today, while the medical literature about health risks in ART is 
increasing, the topic of women’s health in relation to reproductive technologies remains marginal in 
feminist discourse, social sciences, and the mainstream media. On the basis of recent medical studies, 
published in peer reviewed scientific journals, this article aims to begin filling this gap. The author 
discusses adverse effects of ART for three groups of people from a feminist perspective: egg providers; 
surrogate mothers; and children who are born through in vitro fertilization (IVF), heterologous embryo 
transfer (HET), and surrogacy. Among the numerous health problems are ovarian hyper-stimulation 
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diseases. Serious questions arise about the long-term health of women who undergo repeated hormonal 
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exploitation of economically vulnerable women. It also addresses some of the ethical issues arising, such 
as the importance of risk disclosure to potential IVF users, egg providers, surrogate mothers and intended 
parents; children’s right to access all details regarding their genetic origins and their birth mother; and 
relevant psychosocial problems related to the use of ART. This paper calls for renewed critiques of 
women’s experiences with reproductive technologies so that they can become, yet again, an important 
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From their first use in the late 1970s until the mid-1990s, Assisted Reproductive Technologies 
(ART) gave rise to serious concerns by feminists internationally. Their questions ranged from 
asking about health risks to ethical and political problems inherent in these technologies. 
However, over the last 25 years, interest in women’s health which used to be central to feminist 
theory and politics, progressively decreased and with it concerns about ART. Today, while the 
medical literature about health risks in ART is increasing, the topic of women’s health in 
relation to reproductive technologies remains marginal in feminist discourse, social sciences, 
and the mainstream media. On the basis of recent medical studies, published in peer reviewed 
scientific journals, this article aims to begin filling this gap. The author discusses adverse 
effects of ART for three groups of people from a feminist perspective: egg providers; surrogate 
mothers; and children who are born through in vitro fertilization (IVF), heterologous embryo 
transfer (HET), and surrogacy. Among the numerous health problems are ovarian hyper-
stimulation syndrome (OHSS), birth defects, tumours in children, chromosomal damage, and 
cardiac and metabolic diseases. Serious questions arise about the long-term health of women 
who undergo repeated hormonal stimulations, sell their egg cells, or “rent” their wombs as 
surrogate mothers—a process entailing the exploitation of economically vulnerable women. 
It also addresses some of the ethical issues arising, such as the importance of risk disclosure to 
potential IVF users, egg providers, surrogate mothers and intended parents; children’s right 
to access all details regarding their genetic origins and their birth mother; and relevant 
psychosocial problems related to the use of ART. This paper calls for renewed critiques of 
women’s experiences with reproductive technologies so that they can become, yet again, an 
important part of the feminist movement. 
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CIENTIFIC LITERATURE REPORTING HEALTH RISKS in assisted reproductive technol-
ogies (ART) is increasing. In February 2013, a medical study was carried out at The 
Hospital for Sick Children, Toronto University in Canada, by three scientists: Daria 
S 
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Grafodatskaya: Cheryl Cytrynbaum; and Rosanna Weksberg. The results were pub-
lished in the EMBO Report, a journal that communicates major findings indexed by 
the National Center for Biotechnology Information (NCBI), and it appeared in the US 
National Library of Medicine (part of the National Institutes of Health). The authors 
warn: 
There are health risks attached for both mothers and children that need to be 
properly understood and managed. … The most commonly cited health prob-
lems pertain to multiple gestation pregnancies and multiple births. More re-
cently, however, concerns about the risks of birth defects and genetic disor-
ders have been raised. There are questions about whether the required ma-
nipulations and the artificial environments of gametes and embryos are po-
tentially creating short and long-term health risks in mothers and children 
by interfering with epigenetic reprogramming (Grafodatskaya et al., 2013). 
In September 2016, the Committee of the American Congress of Obstetricians and 
Gynecologists (ACOG-Women’s Health Care Physicians) endorsed a document titled 
Perinatal Risks Associated with Assisted Reproductive Technologies. After a review of 
existing studies, based on available data and expert opinion, the Committee published 
the following list of risks associated with ART: 
multifetal gestations, prematurity, low birth weight, small for gestational age, 
perinatal mortality, caesarean delivery, placenta previa, abruptio placentae, 
preeclampsia, and birth defects. Although these risks are much higher in mul-
tifetal gestations, even singletons achieved with ART and ovulation induction 
may be at higher risk than singletons from naturally occurring pregnancies.  
They also issued the following recommendations: 
Before initiating ART or ovulation induction procedures, obstetrician–gyne-
cologists and other health care providers should complete a thorough medi-
cal evaluation to ensure that patients are in good health and should counsel 
these women about the risks associated with treatment. Any maternal health 
problems or inherited conditions should be addressed. Couples at risk of 
passing genetic conditions on to their offspring, including those due to infer-
tility-associated conditions, should be counselled appropriately (The Ameri-
can College of Obstetricians and Gynecologists, 2016). 
Yet, a widespread belief that ART are risk-free technologies dominates media dis-
cussions where the existence of serious health-related problems are rarely acknowl-
edged. There are several reasons for this neglect, the first being the reluctance of the 
international fertility industry to offer complete information about risks when deal-
ing with clients in search of a baby. As documented by Hillary B. Alberta and col-
leagues in relation to the recruitment of egg providers, ART clinics are not eager to 
comply with already vague ethical requirements such as enforcing basic standards of 
informed consent (Alberta et al., 2014). Moreover, laws differ considerably from coun-
try to country, and sometimes from state to state within the same country, as is the 
case in the United States.. Lack of clear regulations are exploited by fraudulent pro-
fessionals (both legal and medical), a phenomenon whose extent and gravity are dif-
ficult to assess (Devine and Stickney, 2012). Such opacity profits from the desire of 
clients to have a child “at any cost,” which leads to the under-reporting and down-
playing of medical, legal, and ethical dangers.  
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From their first use in the late 1970s until the mid-1990s, ART were topics of se-
rious concerns by feminists internationally. These concerns ranged from assessing 
health risks to ethical-political problems inherent in these technologies. Issues of 
choice were addressed as controversial by radical feminists: as a matter of fact, de-
spite the rhetoric of choice surrounding ART, they have not increased women’s repro-
ductive freedom. Indeed, the medical, legal, and commercial developments of ART, and 
the change in the social perception of motherhood through the use of IVF and surro-
gacy have established new forms of control over female reproduction (Bernard and 
Neyer, 2013). Daphna Marcia Inhorn and Birenbaum-Carmeli also asked important 
questions about access to ART in relation to geo-political inequalities, writing that the 
silence surrounding infertility in resource-poor countries may reflect a tacit eugenic 
view that the infertile poor women are unworthy of treatments (Inhorn and Biren-
baum-Carmeli, 2008). 
A reason for the current silence of feminists about health-related topics in the 
contested arena of ART is the unwillingness to assume a position that has the poten-
tial to clash with three categories of people: gay men and trans persons having genetic 
parenting plans; women who are in the market to sell their egg cells and rent their 
wombs, often out of economic need; and the infertile women whose desire for a child 
is enabled by the possibility to buy reproductive services (Corradi, 2017). Such con-
cerns play an important role especially among lesbians, whose frequent embarrassed 
silence on the subject matter has been pointed out (Bonnet, 2018; Lo Moro, 2017). 
So, it came that in feminist circles something strange happened: after much theorizing 
and putting into practice the personal is political, a highly relevant social phenome-
non such as the commercialization of reproduction via surrogacy became relegated to 
personal choice – as if it were simply a matter of freedom: An agreement between two 
women, an equal exchange. The ART industry had already been legitimized by most 
of the medical profession, international lawyers, and the media as welcome saviours 
who were rescuing couples from the pain of infertility.  
In the process of the institutionalization of a significant part of the feminist move-
ment, the critique of medicine and science became less important than efforts to 
break through the glass ceiling and further individual women’s careers; women’s en-
ergies got hijacked toward achieving moderate goals through emancipatory politics, 
equal opportunities, and pink quotas, all of which resulted in a domestication of fem-
inist discourse, activism, and politics. Even a positive phenomenon such as the quan-
titative growth of female professionals in several scientific sectors was partially oblit-
erated by the decline of critical feminist attention towards scientific goals, research 
trends and methods, and how they affect women. Science—once blamed for being pa-
triarchal, racist, heterosexist, and enslaved to the profit system—today seems to be 
accepted as secular dogma, a new religion with neo-liberal ethics. 
In western countries, the initial alertness of the women’s movement to reproduc-
tive health matters progressively decreased. It used to be central to feminist political 
discourse in the 1980s, giving birth (in the following three decades) to a richness of 
feminist books and journal articles critiquing reproductive technologies (among them 
Cockburn, 1981, 1985; Hanmer, 1982; Arditti, Duelli Klein & Minden 1984; Corea, 
1985, Corea et al., 1987; Harding, 1986; Wikler, 1986; Spallone, 1987, 1989; Pateman, 
1988; Woliver, 1989; Chokr, 1992; Anderson, 1993; Duden, 1993; Callahan, 1993, 
1994; Denny, 1994; Spar, 2006; Corradi, 2008; Klein, 2008, Franklin, 2009; Qadeer 
and John, 2009). 
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According to Sara Ainsworth, Director of Legal Advocacy—an organization which 
developed a working group about reproductive technologies—among North-Ameri-
can feminists, critical attention seems to be missing in the field of ART. Legal Advocacy 
took a public stand in a column of the authoritative Washington Law Review:  
Compensated surrogacy—an arrangement in which a woman carries and 
gives birth to a child for someone else in exchange for money—intimately af-
fects women. Yet, feminist law reformers have not led efforts to regulate this 
practice in the United States. Their absence is notable given the significant 
influence of feminist lawmaking in a host of other areas where women's in-
terests are at stake. This lack of feminist law reform leadership can be under-
stood, however, in light of the complex issues that surrogacy raises—com-
plexity that has long divided feminists (Ainsworth, 2014). 
Today, the development of a renewed feminist debate about proven adverse ef-
fects for egg providers, surrogate mothers, and children represents an opportunity to 
overcome the existing silence in feminist discourse about ART, by introducing fresh 
information and different forms of critical understanding. A common ground in the 
women’s movement is much needed around the importance of women’s and chil-
dren’s health in relation to ART; and to reframe the alliance between feminists of di-
verse standpoints and various positions within LGBT-Queer activism. In this article I 
focus on the first task—offering a contribution in terms of recent medical data and 
research results to open a discussion that should not be divisive and go beyond polit-
ical and religious differences in the transnational feminist movement of today.  
In the following three sections I will discuss health risks for different groups of 
women: egg providers; women recipients of HET (heterologous embryo transfer); 
surrogate mothers; and children born from ART. After that I will address psychosocial 
issues and in the last section draw conclusions about some bio-ethical issues that have 
emerged in this work, including advocating for alternative solutions to fertility crises.  
Health Risks for Eggs Providers  
The first type of risk concerns Ovarian Hyper-Stimulation Syndrome (OHSS). 
Women with infertility problems and those who want to sell or donate their eggs have 
to undergo hormonal therapies, which are proven to be harmful to many women (see 
Klein, 2017). Before IVF can commence, hormonal bombardment is necessary in or-
der to get a woman’s ovaries to mature 10 to 20 or more egg cells instead of the one 
or two monthly egg cells that are matured naturally. OHSS may happen and becomes 
manifest after egg retrieval. The hyper-stimulated ovaries are enlarged and can cause 
severe pain, abdominal distension, nausea, vomiting, diarrhoea, thromboembolism, 
fluid on lungs, and even death. Women who produce their gametes for the ART market 
often undergo fertility treatments to stimulate egg cell growth several times a year 
(Barry, 2019). For this reason, they may incur OHSS more frequently than infertility 
patients, a condition leading to serious short- and long-term illnesses, and the risk of 
losing their life. 
Silence was reigning almost undisturbed about health issues for egg providers, 
when on 9 November 2007, a group of feminists organized a seminar titled Trading 
on the Female Body in Oakland, California. A campaign and a blog named handsof-
fourovaries.com were launched. A network of international activists started to work 
with a common mission: Jennifer Lahl (Director of The Center for Bioethics and Cul-
ture Network) in the United States; Josephine Quintavalle (Director of Comment on 
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Reproductive Ethics) in the United Kingdom; Melinda Tankard Reist and Katrina 
George from Australia’s Women’s Forum; and Renate Klein from the Feminist Inter-
national Network of Resistance to Reproductive and Genetic Engineering 
(FINRRAGE). This campaign inspired many new (and old) women activists interna-
tionally, especially after scandals involving egg predation and severe health issues for 
egg providers associated with OHSS. The network “Hands Off Our Ovaries” called for 
a ban on the dangerous practices related to the commercialization of egg cells. 
Initially, IVF was recommended only for women who had problems with their fal-
lopian tubes which made it impossible for their egg cells to descend and be fertilized 
by sperm. Gradually, however, IVF became also used for cases of male low sperm mo-
tility and was prescribed for endometriosis and other pathologies. Increasingly, this 
technology is used without even considering other therapeutic options. Such a liberal 
use of IVF appears less and less justified, as studies documenting health issues for 
women using IVF as well as test-tube babies can now increasingly be found in pres-
tigious international journals (Kamphuis et al., 2014). 
The Journal of Law, Medicine & Ethics highlighted ethical issues in ART by pub-
lishing a study focused on the necessity of informing women donating/selling egg 
cells about potential serious health risks. Indeed, long-term problems may occur, such 
as various types of cancers of the ovaries, womb, colon, or breast, as Hillary B. Alberta, 
Roberta M. Berry, and Aaron D. Levine (2014) emphasized. These authors also ana-
lyzed more than 400 advertisements for the recruitment of egg suppliers, finding that 
the majority did not provide information about these risks.  
Correct timing is also a factor in risk disclosure. Although potential health dangers 
should be communicated by the recruiting agencies to egg providers at the first ap-
pointment, many clinics are reluctant to do this and give information only after weeks, 
when the women have already invested time and energy on medical check-ups and 
meetings. The Ethics Committee of the American Society for Reproductive Medicine 
(ASRM) has produced guidelines stating the necessity to disclose risks when financial 
incentives are involved, but unfortunately these guidelines are not being enforced at 
present.  
The money issue is closely connected to ethical problems. The selling of egg cells 
calls into question social inequalities and problems with personal choice. For egg pro-
viders, the payment is often meant to cover the costs, the time, and their efforts. In 
2005, the European Parliament accepted a resolution1 that prohibits the selling of egg 
cells in member states. But unfortunately, the law does allow reimbursements, thus 
leaving space for the exploitation of low-income women. In some countries such as 
Russia and Ukraine, as well as in several states in the USA, payment in exchange for 
the surgical removal of egg cells is legal and explicitly commercialized.  
However appealing, the sum does not account for the health risks, especially long-
term problems. Women from lower-socioeconomic classes undergo such dangerous 
procedures far too frequently, thus increasing the risk of OHSS and the occurrence of 
fatalities. In terms of medical ethics, the problem is that the egg provider undergoes 
procedures from which she will not benefit herself. She will make a small economic 
gain and possibly feel satisfaction for being useful to others. But she will be left alone 
 
1 A resolution was taken by the European Parliament against the traffic of human ova. Eggs were re-
defined as body parts and the ban on commercialization was approved (Doc B6-0199/2005) voted by 
307 deputies, 199contrary, 25 abstained. https://www.europarl.europa.eu/sides/getDoc.do?pubRef=-
//EP//NONSGML+MOTION+P6-RC-2005-0199+0+DOC+PDF+V0//EN&language=GA  
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with developing health problems, as well as a sense of alienation (see section 5 on 
psychosocial issues). 
Health Risks of IVF and Heterologous Embryo Transfer for Surrogate Mothers  
The use of IVF is expanding despite the increases of serious health risks for preg-
nant women: multiple pregnancies2 are associated with maternal and perinatal com-
plications such as gestational diabetes, fetal growth restriction, pre-eclampsia, prem-
ature births and even death (Riben 2015). Even singletons born through IVF have 
been shown to have worse outcomes than those conceived naturally. Although a few 
countries have mitigated the risk of multiple births by requiring single embryo trans-
fer, multiple transfers are still common in many states of the world, including in the 
United States and Asia, where multiple birth rates are 20% to 30%. Furthermore, 
studies suggest that even a single embryo transfer (which involves an extended em-
bryo culture before the implantation of a blastocyst in the woman’s womb) is associ-
ated with a 50-70% additional risk of preterm birth and congenital malformations 
(Kamphuis et al., 2014).  
Additional problems appear in case of Heterologous Embryo Transfer (HET), that 
is, the transfer of a genetically unrelated embryo into the womb of a woman. This 
technology is used to help women who cannot conceive with their own eggs (e.g., be-
cause of their age or undergoing cancer treatment), as well as in gestational surro-
gacy.3 The women who are recipients of embryos created with another woman’s eggs 
have experienced documented health issues. Pregnancies following egg donation are 
reported to more than triple the risk of high blood pressure (hypertension) (Euro-
pean Society of Human Reproduction and Embryology, in ScienceDaily, 1 July 2014) 
and lead to other problems that need to be further investigated, such as higher level 
of implantation failure and lower live birth rates.  
In 2014, the Journal of Perinatology published a study about ART, including arti-
ficial insemination (AI),4 which highlighted worrying results in California: 
 
2 The implantation of several embryos is believed to increase the chances of a successful pregnancy, but 
the number of embryos that should be transferred is still controversial. The Practice Committee of the 
American Society for Reproductive Medicine, and the Practice Committee of the Society for Assisted Re-
productive Technology produced a document called Guidance on the limits to the number of embryos to 
transfer a committee opinion (2017). https://www.asrm.org/globalassets/asrm/asrm-content/news-
and-publications/practice-guidelines/for-non-members/guidance_on_the_limits_to_the_num-
ber_of_embryos_to_transfer.pdf  
3 HET can also be performed in the case of adoption of abandoned embryos, a practice that has been 
sponsored by Catholic medical services which attribute dignitate personae to the embryo. However, the 
role of women as simple carriers in surrogacy goes unquestioned by most Catholics. On related moral 
issues see Accad (2014). 
4 The difference between artificial insemination (AI) and in vitro fertilization (IVF) is that the first hap-
pens in the woman’s body, the second in a petri dish (popularly called a test-tube). In AI, previously 
selected sperm is introduced into the woman’s uterus after the uterine lining has been prepared by stim-
ulating ovulation with hormonal drugs. IVF consists of retrieving ripe egg cells from a woman’s ovary, 
fertilize them in the laboratory with sperm, and later insert the developing embryo(s) into the woman’s 
uterus. The difference between IVF and ICSI (intra-cytoplasmic sperm injection) pertains to the method 
of achieving fertilization. After gametes (egg cells and sperm) are collected from each partner, in IVF, the 
egg cells and sperm are mixed together in a petri dish and the sperm fertilizes the egg cells naturally, 
whereas in ICSI, one good sperm is selected by embryologists and inserted into the egg cells with a sy-
ringe. ICSI is used for the increasing group of sub-fertile men who produce only few sperm cells. 
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In 2009, births in California accounted for 12.8% of all US resident births. 
Women in California underwent 18,405 ART procedures in 2009, of which 
15,953 embryos were transferred, resulting in 7155 pregnancies and 5710 
live births, of which 30,1% were multiple births. … Among ART/AI pregnan-
cies there was a 4-5 fold increase in stillbirth identified from 2009 to 2011 
compared with women whose pregnancy occurred naturally … ART/AI con-
ceived pregnancies also experienced increased rates of caesarean section 
with associated complications and co-morbidities (41% on average), which 
were increased four-fold compared with those among naturally conceived 
pregnancies (10% on average). … 2-3-fold increase in known or suspected 
foetal anomalies among ART or AI compared with naturally conceived infants 
(Merritt et al., 2014).  
This study indicates how the additional costs for maternal care attributable to 
ART, and the substantially higher hospital charges for infants delivered after ART/AI 
are a growing medical economic concern for Californians and for health policymakers 
nationwide. In fact, ART considerably extends the hospitalization time for mothers 
and intensive care for children, which can become a heavy burden for public health 
systems as well as for private insurance (Nicolau et al., 2015). In addition there can 
be psychosocial problems for the women and their families who are impacted by such 
unexpected adversities (see section 5. below). 
There are other health risks for recipients of HET and surrogate mothers, related 
to the drugs administered before the implantation of the embryos. Some research 
found an increase in gestational diabetes (which does also impact the foetus), and 
intracranial hypertension among surrogate mothers while they prepare for gesta-
tional surrogacy because of the use of medicines and hormones (Alexander and Levi, 
2013). Besides the normal risks associated with serial pregnancies, it is highly likely 
that recipients of HET and surrogate mothers experience miscarriages and still births 
at higher frequency, with their known physical and psychological consequences for 
women. 
Health Risks for Children 
Even though medical studies on surrogacy advocate the follow-up of children born 
from ART (Corradi, 2017 and 2018), long-term consequences are not fully investi-
gated. Few studies mention the risk of early forms of cancer. A Japanese study pub-
lished in the Journal of Human Genetics found an association between the use of ART 
and several illnesses, including child tumours (Higashimoto & Soejima, 2013). One of 
the early studies pointing out health problems for newborns from reproductive tech-
nologies came from France. More than 15 years ago, ART babies already represented 
1.3% of the total birth defects, according to the annual official data of the French Min-
istry of Health. Genetic alterations were found among those born with IVF and AI, and 
scientists asked for careful monitoring of these children (Gicquel et al., 2003).  
In 2017, the American Journal of Obstetrics and Gynecology published a study 
about the long-term health effects on offspring conceived after fertility treatments. An 
association was found between the mode of conception (in vitro fertilization, ovula-
tion induction, or spontaneous pregnancy) and tumour (neoplasm) risk, which in-
cludes benign and malignant types of tumours among the offspring. This was a longi-
tudinal study in which the scientists observed large numbers of children for up to 18 
years, finding that the rate of neoplasms was higher among children conceived 
through in vitro fertilization or ovulation induction treatments, as compared to natu-
rally conceived children. The researchers’ conclusion was unambiguous: “Children 
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conceived after fertility treatments are at an increased risk for paediatric neoplasms” 
(Wainstock et al., 2017).  
An article by Philip Hunter (2017) on the long-term health risks from ART pub-
lished in the Journal of European Molecular Biology Organization (EMBO Press) 
pointed out that based on both epidemiological data and research on animals, in vitro 
fertilization can create health problems later in life. There are conditions related to 
the genetic makeup of the parents. According to Hunter, subfertility “does not seem to 
be just an isolated condition, but is often associated with other deficiencies that seem 
to heighten the risk of various diseases for the child.” He further comments that IVF 
procedures are also controversial for intrinsic reasons: “A factor affecting both preg-
nancy rates and possibly health risks for the child that has been fully recognized only 
recently is the oxygen concentration of the embryo culture conditions.” Philip Hunter 
points out that 40 years after the birth of the first IVF baby in 1978, the significant 
body of studies produced is still considered “inconclusive” proof for what is glaringly 
obvious: “significantly increased levels of serious conditions, including cancer, car-
diac, or metabolic diseases” (Hunter, 2017). 
The World Journal of Clinical Pediatrics published the results of a medical re-
search project confirming what emerged in several earlier studies—children con-
ceived through IVF have a higher rate of brain damage (Bellieni et al., 2011), often 
associated with multiple gestation. But even for babies that were implanted as single 
embryos, the risk was found to be higher, which calls into question the techniques 
related to IVF including embryo cultures, and the low quality of egg cells usually ob-
tained after the administration of fertility drugs and hormone therapies. 
The sequence of procedures around cryopreservation (the use of very low tem-
peratures to preserve structurally intact living cells and tissues) are also still debata-
ble. A comparative study found some issues related to the stage in which embryos are 
implanted, in terms of determining the success of the operation: “Cryopreserving em-
bryos at the zygote stage [the newly fertilised egg] was associated with lower survival 
rates and lower implantation rates compared with freezing at the blastocyst stage 
[approximately 200 cells on day 5 after fertilization]” (Pavone et al., 2011, p. 27, see 
also Hidenobu and Higashimoto, 2013). Yet the most sensitive phase is when embryos 
are defrosted. This question has come under scientific scrutiny because there could 
be implications in terms of epigenetic damage: 
The efficiency and safety of cryopreservation methods is usually assessed by 
measuring cell survival rates immediately after thawing, but this parameter 
does not measure the impact of more subtle effects on cellular processes, and 
in particular on epigenetic mechanisms. Such epigenetic marks control the 
expression of genes and reflect the influence of developmental and environ-
mental factors. Moreover, epigenetic marks can be passed on to daughter 
cells through cell division. There is also increasing evidence that epigenetic 
markers can be passed on through sexual reproduction via gametes and can 
influence disease risk or even cause disease in the next generation (Chatter-
jee et al., 2016, p. 294). 
A 2012 Chinese research project based on quantitative meta-analysis took into 
consideration a large number of scientific investigations regarding birth defects 
among children conceived via in vitro fertilization and more specifically intra-cyto-
plasmic sperm injection (ICSI, see Footnote 4). These explorations led the scientists 
to create a database of studies and the formulation of six main sites of birth defects: 
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nervous system; genitourinary system; digestive system; circulatory system; muscu-
loskeletal system; and ear, face, and neck. Findings indicate significant relations be-
tween IVF/ICSI and the mentioned types of birth defects (Wen et al., 2012).  
A 2016 study published in the Journal of American Medical Association (JAMA Pe-
diatrics) shows evidence that the use of ART increases birth defects, in particular, of 
the gastro-intestinal and musculoskeletal systems (Boulet et al., 2016). The disturb-
ing results of this 10-year long investigation motivated the scientists to recommend 
that risks be disclosed to patients looking for advice whether to begin IVF. A 2015 
meta-study published in Fertility and Sterility, the journal of the American Society for 
Reproductive Medicine (ASRM), assessed whether children conceived by ART are at 
increased risk of childhood illnesses compared with spontaneously conceived chil-
dren. Results indicated that children conceived with ART may be at increased risk of 
unspecified infectious and parasitic diseases, asthma, genitourinary diseases, epi-
lepsy or convulsions, and longer hospitalizations (Kettner et al., 2015). 
In July 2018, paediatric oncologist Maura Massimino participated in the Interna-
tional Symposium on Pediatric Neuro-Oncology (ISPNO) held in Denver, Colorado, 
where a world congress of scientists belonging to different medical fields gathered to 
discuss brain cancer in children. She reported):  
I am impressed about the data presented by the European Registry on the 
pathology regarding the correlation between Assisted Reproductive Technol-
ogies (ART) and the incidence of atypical teratoid/rhabdoid tumors. This is 
a very aggressive embryonal type of cancer, hitting very small children, often 
newborns; in a certain percentage of the cases such a pathology has to do 
with a genetic syndrome affecting multiple tumors at birth or during later life 
(pers.comm.).  
Since then, an increasing number of research projects have focussed on cancers 
in children related to ART. On November 8, 2020, the on-line Journal Bioedge reported 
the results of a study carried out in Massachusetts, New York, Texas, and North Caro-
lina: “Children conceived with IVF have a higher risk of developing cancer than those 
conceived naturally” (Cook, 2020). According to this study published in the jour-
nal JAMA Network Open, the increased risk was two-fold higher for children conceived 
via in vitro fertilization than for children conceived naturally, say the authors (Luke, 
Brown and Nichols 2020).  
Psychosocial Issues  
Studies suggest the occurrence of problems in families where babies have been 
created with “donation” of gametes or surrogacy. There is a negative impact on chil-
dren’s psychological well-being resulting from the lack of a “bio-social connection” 
with the surrogate mother.5 An investigation by the Centre for Family Research of 
Cambridge University compared the difficulties found among children from surrogacy 
with those born through egg or sperm donation. Researchers conclude that the ab-
sence of a connection with the surrogate mother (who gives birth to them) is more 
problematic for children then the absence of a link with the genetic donors (Golom-
bok et al., 2013). In other words, while “paternity” and “maternity” are socially con-
structed, nine months of a generative relationship (Corradi 2017, 2019) during the 
 
5 Similar issues are also found among children in adoptive families, having to do with previous traumas, 
abandonment, abuses, and multiple custodians (Corradi, 2017, 2019). 
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whole pregnancy cannot be ignored as a mere biological issue. The surrogate mother 
is not just a simple “carrier,” but one of the two elements of a living dyad, having bio-
logical, emotional, and some genetic exchanges with the developing child. With do-
nated gametes, an intended mother receiving a genetically unrelated HET embryo has 
the possibility to grow the child in her womb, thus forming an important physical tie 
with him/her during pregnancy, delivery, and nursing. In the case of gestational sur-
rogacy, on the other hand, it is precisely such elements of connection that are com-
pletely missing (McGee et al., 2001). Negative outcomes after the separation of the 
newborn from the woman who just delivered him/her have been studied in the last 
decade (Morgan et al., 2011). After birth, the surrogate’s breasts are full of milk and 
she must undergo hormonal treatments to stop the milk flow (lactogenesis). Psycho-
logically, after delivery, the surrogate mother may feel attached to the child she gen-
erated during pregnancy and to whom she gave birth.  
Some researchers appear to downplay these issues: a longitudinal research pro-
ject by Jadva, Imrie and Golombok (2014) points out findings that are meant to be 
reassuring, such as the one that after 10 years, surrogate mothers do not view the 
delivered child as their son/daughter anymore. However, I believe that this should be 
interpreted at the very least as a problematic outcome: If for up to ten years the sur-
rogate mother feels an emotional attachment to the baby, she gave birth to, this is a 
disturbing finding. And when surrogate mothers still feel some special tie with the 
child it would be only in cases of gestational surrogacy which seems to contradict 
common sense. In fact, a surrogate mother is more likely to feel more attachment to 
the newborn she conceived with her own egg, than with the egg of another woman. 
This is the reason why there was a shift from traditional to gestational surrogacy, 
which is the preferred method today, and was in Jadva et al.’s study. According to this 
study, 10 years after the birth of the child they were separated from, surrogate moth-
ers would “score within a normal range for self-esteem.” Furthermore, they would 
show no signs of depression. And the most surprising finding regarding relations with 
their partner was that surrogates declared the quality of their marriages remained 
positive over the 10 years, a result that is hard to achieve even for women who do not 
engage in surrogacy.  
Surveys of surrogate mothers seem to emphasize their satisfaction, and amongst 
their personal motivations the focus is on altruistic purposes and philanthropic en-
thusiasm—a desire to help childless couples and a feeling of solidarity with other hu-
man beings. There are also reports of positive feelings such as the pleasure of preg-
nancy (Edelman, 2004; Imrie & Jadva, 2014). Yet, there is no acknowledgement in this 
research that surrogates are used to give testimonials for the IVF clinics; they must 
appear stress-free and convincingly happy.6 
In reality, besides the known problems dealt with by expecting mothers, surro-
gates have additional problems, since they undergo more hormonal therapies than 
naturally pregnant women (pre- and post-implantation of the embryo) and constant 
medical check-ups and tests. Surrogates experience several forms of dispossession 
related to the loss of privacy, including being subjected to controls of their behaviours 
in their own house. They lose sovereignty over nutrition and lifestyle; even the pres-
ence of pets can be restricted in surrogacy contracts. Surrogates are more at risk of 
 
6 For information on surrogacy in India, Thailand and Nigeria see Bhadra, 2017; Makinde et al., 2017; 
The Economist, 13 May 2017; Saravanan, 2018. 
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pregnancy misadventure than other mothers because of the higher rate of miscar-
riages and stillbirths. If they are not able to hand over the final “product,” they will 
miss out on most of the expected monetary compensation. Furthermore, surrogates 
may suffer from the separation with the child after delivery. After giving birth to the 
child, they may not perceive him or her as just an “outcome of their reproductive 
work.” Becoming milk providers—an alternative mentioned in some contracts—
would certainly be beneficial for the child. Yet such an option can aggravate the diffi-
culties for surrogate mothers, because they must prolong the reproductive exploita-
tion of their bodies, and the connection with a child with whom they will never have 
a sustained relationship. For these reasons, becoming a milk provider may increase 
their sense of alienation. 
Even though fertility business advertisements show smiling pregnant surrogate 
mothers, seemingly to reassure customers they never have problems in generating 
children for others, a number of former surrogate mothers founded a National Coali-
tion Against Surrogacy in the 1990s to oppose surrogacy.7 Mainstream media contin-
ues to be pro-surrogacy and represents it as an expression of a woman’s choice, or a 
fruitful mutual exchange between free consenting adults. The disparity in economic 
status, education, social power, race/caste and geopolitical privilege is rarely men-
tioned. What we need is an intersectional analysis of former surrogate mothers’ expe-
rience: Looking at their vulnerabilities is by no means a way to disempower women. 
On the contrary, it is crucial to study the role of inequalities in terms of class, race, 
status, education, and geopolitical privileges. Surrogacy cannot be simplistically ex-
plained as a form of solidarity among women or care work as it was argued in a paper 
presented by L. M. Anabel Stoeckle at the International Sociological Association (ISA) 
held in Vienna (2016). 
At times, journalists have documented relations between surrogacy and crime. On 
July 27, 2014, The New York Times published an article on “ghost clinics” in Mexico 
and the phenomenon of babies sold in the illegal market—stolen from both the in-
tended parents and the women who had delivered the babies (Lewin, 2014). But these 
events are simply shown as unfortunate and rare episodes—like cases of a few rotten 
apples. The mainstream media tends to focus on success stories, such as the celebra-
tion of Carole Horlock, Britain’s most prolific surrogate mother, who had 13 babies for 
couples and happily retired in 2016—while paying no attention to health issues re-
lated to ART, either her own or those of her children.  
Psychosocial issues have also emerged among people who donate their gametes 
and who may have second thoughts even years after the separation from what was 
considered, at that time, simply bio-materials. A study published in the scientific jour-
nal Human Reproduction reports the experience of sperm and egg donors who even-
tually met their offspring. An online questionnaire was administered through an or-
ganization whose aim it is to put in contact “the two parts of a biological relation” 
(Jadva et al., 2014). The survey revealed a big difference between women and men: 
During their lifetimes, women had donated oocytes from one to five times, while men 
 
7 On September 1, 1987 several surrogate mothers, including Mary Beth Whitehead of the celebrated 
Baby M case and Elizabeth Kane, joined forces with a group of feminists (Phyllis Chesler, Gena Corea and 
Janice Raymond, among others) and biotechnology opponents (Jeremy Rifkin) to announce the for-
mation of a National Coalition Against Surrogacy. The Coalition was very active until the mid-1990s and 
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provided sperm from one to 950 times. Also, more than 50% of men and more than a 
third of women mentioned thinking about the wellbeing of the children born from 
their gametes, and some regret about not being in touch with them. 
The majority wanted to know how many children with their genes were born. Half 
of them asked for information to identify their offspring; all who succeeded in getting 
in touch with the children reported the experience as positive; and the majority of 
them established an ongoing relationship. They referred to their offspring as sons or 
daughters during the interviews (Jadva et al., 2014). These research findings should 
not be generalized, yet I believe such subjective perceptions merit serious considera-
tion. Furthermore, access to information regarding biological relations should be dis-
closed. In the Netherlands, the U.K., Norway and Australia, legal obstacles have al-
ready been removed in favour of transparency ahead of privacy and anonymity.  
In fact, secrecy can be unsettling for children. Bioethicists at the University of 
Pennsylvania in Philadelphia believe that giving information to offspring regarding 
their conception through donation and/or surrogacy should not be optional. Children 
may get to know the truth later in life anyway, and in addition to the specific stress of 
learning important details about their birth, they would have to cope with a feeling of 
betrayal toward those who concealed the truth (Brakman et al., 2001). Keeping a fam-
ily secret implies the creation of an artificial psychological environment around the 
child. Everybody who knows the truth tries to keep it hidden. Sudden embarrass-
ments, allusions, silences, broken phrases, enable children to understand that some-
thing is hidden from them, even if they don’t know what it is (Corradi, 2017).  
The fact that their parents are not open about an issue as important as their origin 
is a violation of children’s autonomy. When they grow up, they may get to know the 
truth in different ways. Jennifer Lahl, one of the founders of the international advocacy 
group Stop Surrogacy Now8 interviewed a young woman named Jessica Kerns who 
calls herself a product of surrogacy (Lahl, 2015). Born through commercial surrogacy, 
she was the first activist to give a voice to people brought into the world through a 
third-party reproduction contract. Talking about her experience, she gives people 
who are considering surrogacy the chance to understand issues that are usually con-
cealed. Jessica Kerns also talks about “The Other Side of Surrogacy” in her blog, where 
she explains that surrogacy and human trafficking should not be regarded as different 
phenomena because the distinction is purely formal: “If you sign the document before 
the mother gets pregnant it is surrogacy; if you sign it when she is pregnant it is hu-
man trafficking” (Kerns, 2014). The difference between surrogacy and the illegal mar-
ket of children would thus only depend on the time when the contract is signed. How-
ever, it is undisputable that when you are born, you are a human being and nobody 
should be able to sell you, buy you, or give you away as a gift. The implication of chil-
dren being sold and bought, is one of the reasons for considering surrogacy “a human 
rights violation” as Renate Klein points out in her book Surrogacy. A Human Rights 
Violation (2017). 
Swedish feminist Kajsa Ekis Ekman, author of the book Being and Being Bought. 
Prostitution, Surrogacy, and the Split Self (2013), analyses the different ways in which 
 
8 Stop Surrogacy Now was founded in 2015 as an international advocacy group with the aim to abolish 
all forms of surrogacy. It is housed by the Center for Bioethics and Culture in California (CBC) and spear-
headed by its president Jennifer Lahl. At the time of writing (February 2021), more than 12000 individ-
uals have signed its position paper. See https://www.stopsurrogacynow.com. The CBC has also pro-
duced a number of films relevant to ART, e.g., Eggsploitation; Breeders: A Subclass of Women; Big Fer-
tility: It’s All about The Money, and produces a regular Podcast (http://www.cbc-network.org/film/).    
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talking about surrogacy as a service is misleading. The surrogate mother is not rent-
ing her womb—she is giving up her whole body’s sovereignty for the whole duration 
of her pregnancy. Given that she is paid upon delivery of the child and on the signature 
of required documents, she is de facto selling the product of her reproductive labour, 
in a way that is quite different from selling an organ. In the case of surrogacy, the ob-
ject of the payment is a person. The commercial split between sex and reproduction 
produces other splits at the level of self and between the two women. There is a dou-
ble transfer of pain where the woman commissioning the baby is suffering because 
she cannot have a child of her own. She may experience a feeling of alienation, for not 
having been able to be pregnant and give birth to a child herself, and for having taken 
advantage of another woman by virtue of her/her partner’s economic privilege. While 
the surrogate mother is getting paid to make her happy, she may be left with a sense 
of loss and alienation for having given up the child she gave birth to, and with a sense 
of anguish for having no connections with him/her. In such a relationship, the burden 
of pain is not shared; actually, it may have multiplying effects. 
In the 2019 book, Broken Bonds. Surrogate Mothers Speak Out, 16 stories by 
women who rented their wombs or provided their eggs to others demonstrate more 
convincingly than any medical study how these technologies are not creating happi-
ness or freedom—they are sources of misery and alienation (Lahl, Tankard Reist & 
Klein, eds. 2019). The scientific mission of perfecting nature seems to be requesting a 
high price of sorrow and a burden of physical and psychological illness while produc-
ing huge profits for the ART industry, Big Pharma, and the omnipresent agents of bio-
markets.  
In her study carried out in India, Sheela Saravanan (2018) interviewed 13 surro-
gate mothers, four intended parents and two doctors with an intersectional method-
ology. Saravanan’s work based on the concept of reproductive justice offers a useful 
perspective on bridging feminist factions divided by contextual and ideological 
grounds toward building global feminist solidarity beyond underlying race, class, 
caste, gender, sexuality, ability, age, and immigration oppressions (Saravanan 2018). 
Conclusion: Assisted Reproductive Technologies in the Time of a Fertility Crisis 
and Renewed Feminist Resistance 
In this paper I discussed different physical health problems and psychosocial is-
sues impacting women using IVF, egg providers, surrogate mothers, commissioning 
parents, and children gestated with these technologies. Much more research is needed 
on all aspects of ART: we are facing the creation of a category of breeders: women in 
poor countries or migrants, women of colour, or from the white lower classes—often 
in need of paying their mortgages or sending their children to college—who are gen-
erating children for (economically better off) third parties (Smith, 1999; El Bou-
damoussi and Rainhorn, 2015). Such a social process cannot be seen as unproblem-
atic or treated as a personal issue. The performative task of creating a baby should be 
re-considered, in feminist research and the social sciences, through the prism of an 
intersectional approach. 
This is especially important because, as I have shown in this paper, there is a grow-
ing list of documented serious short- and long-term health risks in peer reviewed 
medical journals for women and children born from ART that should be discussed 
together with the social and ethical questions I mentioned. Other issues relate to the 
right to know of several subjects involved in ART and to risk disclosure about poten-
tial harms. Should women who consider selling their egg cells or serving as surrogate 
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mothers not be fully informed about the risks for their health through the medical 
research studies available today? Should intended parents (be they infertile couples, 
single women, lesbians, gay men, intersexual or transsexual people) not have the right 
to know about adverse health effects of ART on the babies they pay for? Should the 
children born via donation of gametes and/or surrogacy not know all the details 
about their genetic origins and who gave birth to them? Do these children not have 
the right to be born healthy? As feminists, we should strongly advocate for full disclo-
sure of these issues and use intersectional approaches in finding solutions to ART, 
health, and social ethics, by making a clear distinction between reproductive rights 
and reproductive privileges (Corradi 2008) thus aiming for global reproductive jus-
tice as suggested by Sheela Saravanan (2018). 
Several years before Thailand, Nepal, Cambodia and India decided to stop being 
rent-a-womb countries, in their article The business and Ethics of Surrogacy (2009), 
feminist social scientists Imrana Qadeer and Mary E. John from the Centre for 
Women’s Development Studies in New Delhi proposed two relevant transformations 
that are still valuable today: the improvement of global laws to facilitate adoptions for 
infertile and gay couples; and a cultural change to overcome negative social attitudes 
about infertility itself. They were the first to point out the obligation of the (Indian) 
state to protect the rights of surrogate mothers, who by law should be assured they 
have the right to keep the child if they cannot part from him/her, and the right to have 
their name on the child’s birth certificate. Intended parents should be required to 
guarantee the surrogate mother all rights in terms of autonomy, privacy, and bodily 
integrity—an important concept when we are dealing with situations of medical harm 
and economic inequality. A child should be universally considered as a result of 
women’s generative capacity, not a commodity whose value is assessed by the market 
(Qadeer and John, 2009). 
Technology is often presented as a panacea, able to solve social issues. So called 
ethical sex selection or family balancing refer to the process of implanting only male 
embryos—presented as an alternative to selective abortion of female foetuses. Such a 
solution is neither ethical nor socially useful because it doesn’t solve the problem of 
discrimination against female children, and negatively impacts the birth rate of fe-
males. As a matter of fact, implanting only male embryos makes gender inequality 
worse. When boys outnumber girls, legitimizing the social preference for males and 
increasing the social stigma attached to having female babies, the result is a crystalli-
zation and strengthening of patriarchal problems (Corradi 2017). 
In industrialized countries, fertility in both women and men is undoubtedly on 
the decline and resorting to ART may become an even more common phenomenon.9 
We know that environmental pollution and the widespread presence of physical and 
chemical carcinogens adversely affect our genetic makeup, reproductive potential and 
the future health of our offspring. Today, exposure to chemical and physical carcino-
gens translates into damages to the children of tomorrow and lowers their reproduc-
tive capabilities. But ART cannot be seen as the solution to social and environmental 
problems such as increasing infertility. Answers may be found in ecologically 
grounded prevention policies, in cultural changes around the idea of maternity and 
parenting, and laws that allow single women, LGBT members, and alternative families 
to adopt children in countries where this is still prohibited (Corradi 2019). Women’s 
 
9  See the information on infertility by the U.S. Centers For Disease Control and Prevention on 
www.cdc.gov/reproductivehealth/infertility 
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health has historically been a common ground for feminist activism—it should re-gain 
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